Cyclosporin formulation
US6312721A · kind A · utility
2Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2000 |
| Grant date | Nov 6, 2001 |
| Priority date | — |
| Expiry date | Jul 26, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are therapeutic compositions which provide high bioavailability of the active ingredients from the group of cyclosporin, at the same time permitting concentrations in dosage forms higher than 10%.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.